AtriCure, Inc., was incorporated in Delaware on October 31, 2000. The company is a leading innovator in surgical treatments and therapies for atrial fibrillation, left atrial appendage management and postoperative pain management. The company's cardiac ablation and left atrial appendage management products are used by physicians in open heart and minimally invasive surgery. The company's pain management solutions are used by doctors to freeze nerves during heart, chest or amputation surgery. The company's cryoICE frozen balls and cryoXT probes for pain management provide temporary relief of postoperative pain, allowing the patient's body to heal after surgery, while nerve regeneration and sensory recovery. The company sells to medical centers through its direct sales teams in the United States, Germany, France, the United Kingdom, the Benelux region, Australia and Canada. The company also sells its products through distributors, who in turn sell their products to medical centers in other international markets.
